HOWL | Werewolf Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.0850 - 2.4200
52 Week Range	1.5740 - 8.19
Beta	0.07
Implied Volatility	528.33%
IV Rank	29.07%
Day's Volume	273,441
Average Volume	307,559
Shares Outstanding	43,702,200
Market Cap	93,522,708
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-04-30

Valuation
Profitability
Growth
Health
P/E Ratio	-1.55
Forward P/E Ratio	N/A
EPS	-1.38
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	45
Country	USA
Website	HOWL

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

HOWL's peers: BCLI, BMEA, CALT, CELC, CERE, CLNN, DNLI, DSGN, DYAI, ENTA, EQ, EWTX, FBRX, GHRS, GLUE, IKNA, STOK, DBTX, CCCC, TALS, ACET, CGEM, VOR, THRD, PASG, ACRV, ELYM, MOLN, MNOV, ANEB, CSBR, CYT, IFRX, IGMS, INBX, INKT, IOBT, KZR, LBPH, MDXG, NVCT, ORIC, PHVS, RAPT, RPHM, SRRK, TARS, TYRA, XOMA, GRI

*Chart delayed

Analyzing fundamentals for HOWL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see HOWL Fundamentals page.

Watching at HOWL technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HOWL Technicals page.